MedPath

Effect of Fetuin A in Hemodialysis Patients

Conditions
Hemodialysis
Malnutrition
Registration Number
NCT00309426
Lead Sponsor
University of Shizuoka
Brief Summary

The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.

Detailed Description

Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Hemodialysis for at least 6 months
Exclusion Criteria
  • Disabled patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maruyama Hospital

🇯🇵

Hamamatsu, Shizuoka, Japan

© Copyright 2025. All Rights Reserved by MedPath